Oorsprong van het eerstegraads netwerk van Ichiro Otsuka
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 37 | |
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan.
31
| Subsidiary | Pharmaceuticals: Major | 31 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ichiro Otsuka via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| W WORL | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Bayer Pharmaceuticals Corp. | President | ||
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The private company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Zielbio, Inc.
 Zielbio, Inc. Medical SpecialtiesHealth Technology Zielbio, Inc. develops a technology for identification of cancerous diseases. Its technology identifies high-value biomarkers of disease as well as companion targeting peptides capable of delivery of therapeutic payloads and as imaging agents. The company was founded by Kimberly A. Kelly, Gregory B. Fralish, Todd William Bauer in 2010 and is headquartered in Charlottesville, VA. | Medical Specialties | Chairman | |
| OTSUKA PAKISTAN LIMITED | Pharmaceuticals: Major | Director/Board Member Chairman | |
Otsuka Pharmaceutical Factory, Inc.
 Otsuka Pharmaceutical Factory, Inc. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member President Chief Tech/Sci/R&D Officer | |
Taiho Pharmaceutical Co., Ltd.
 Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member Chairman President | |
| Concordia College (New York) | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| V V FOOD & BEVERAGE CO.,LTD | Food: Major Diversified | Director/Board Member | |
Otsuka America, Inc.
 Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chairman President Chairman Director/Board Member President Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chairman Chairman Chief Executive Officer General Counsel | |
| Lederle International | Corporate Officer/Principal | ||
| MICROPORT SCIENTIFIC CORPORATION | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Shanghai Microport Medical (Group) Co., Ltd.
 Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Otsuka Chemical Co., Ltd.
 Otsuka Chemical Co., Ltd. Chemicals: SpecialtyProcess Industries Otsuka Chemical Co., Ltd. engages in the production of chemicals and diet supplements. It provides inorganic salts, bromides, hydrazine, foaming agent, polymerization initiator, preparation articles, rust-preventive agent, fire retarding material, intermediates, and electro-organic synthesis products. The company was founded on August 29, 1950 and is headquartered in Tokyo, Japan. | Chemicals: Specialty | Director/Board Member Director/Board Member Chairman Comptroller/Controller/Auditor | |
Otsuka Foods Co. Ltd.
 Otsuka Foods Co. Ltd. Food: Major DiversifiedConsumer Non-Durables Part of Otsuka Holdings Co., Ltd., Otsuka Foods Co. Ltd. is a Japanese company that specializes in processed foods, frozen foods, and beverages. The private company is based in Osaka, Japan. The company's website features information about their products, corporate information, safety and security initiatives, campaign information, and commercials. One of their products is milk tea with a deep and rich taste, which aims to bring the taste of the restaurant to the comfort of one's home. | Food: Major Diversified | Chairman Chairman President | |
Nature Made Nutritional Products, Inc.
 Nature Made Nutritional Products, Inc. Pharmaceuticals: OtherHealth Technology Nature Made Nutritional Products, Inc. engages in the provision of health care prooducts. It offers CholestOff, TripleFlex, Probiotics, and SAM-e. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member | |
Otsuka Medical Devices Co., Ltd.
 Otsuka Medical Devices Co., Ltd. Medical SpecialtiesHealth Technology Otsuka Medical Devices Co., Ltd. engages in medical equipment business focusing on therapeutic devices. Its devices include ultrasound-based renal denervation, drug device combinations, and novel solutions for drug-refractory patients and intractable diseases. The company was founded on February 15, 2011 and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member Chief Executive Officer President Director/Board Member | |
| MicroPort Medical Ltd. | Director/Board Member Director/Board Member | ||
| Leader City Ltd. | Director/Board Member Director/Board Member | ||
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MicroPort Lifesciences (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
| MicroPort Lifesciences (Beijing) Co. Ltd. | Director/Board Member Director/Board Member | ||
| MicroPort Orthopedics Shanghai Co. Ltd. | Director/Board Member Director/Board Member | ||
| MicroPort NeuroTech (Shanghai) Co., Ltd. | Director/Board Member Director/Board Member | ||
| SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. | Medical Specialties | Director/Board Member Director/Board Member | |
| D-Pulse Medical (Beijing) Co. Ltd. | Director/Board Member Director/Board Member | ||
| Dongguan Kewei Medical Co. Ltd. | Director/Board Member Director/Board Member | ||
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chairman | |
Field Trip Health, Inc.
 Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Director/Board Member | |
Field Trip Psychedelics, Inc.
 Field Trip Psychedelics, Inc. Medical/Nursing ServicesHealth Services Field Trip Psychedelics, Inc. operates as a mental wellness company. It offers psychedelics and psychedelic-enhanced therapies. The company was founded on April 2, 2019 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Director/Board Member | |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Umoja Biopharma, Inc. engages in the development of immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. It offers an integrated cellular immunotherapy platform comprising VivoVec in vivo delivery, RACR/CAR synthetic receptor payload and TumorTag targeting technologies that attack cancer cells. The company was founded by Michael Jensen, Philip Low, Andy Scharenberg and Ryan Crisman and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chairman | |
| COYA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Essenlix Corp.
 Essenlix Corp. Medical SpecialtiesHealth Technology Essenlix Corp. develops an instant mobile health self-test platform. The private company is based in Monmouth Junction, NJ. The company was founded in 2013 by Lin Chou and Stephen Y. Chou. | Medical Specialties | Chairman | |
| ATAI LIFE SCIENCES N.V. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mnemo Therapeutics SAS
 Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chairman | |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 22 |
| China | 13 |
| Japan | 6 |
| Canada | 5 |
| Frankrijk | 3 |
Sectoraal
| Health Technology | 29 |
| Commercial Services | 4 |
| Health Services | 4 |
| Consumer Services | 3 |
| Consumer Non-Durables | 3 |
Operationeel
| Director/Board Member | 154 |
| Corporate Officer/Principal | 47 |
| Chairman | 44 |
| President | 29 |
| Independent Dir/Board Member | 28 |
Sterkste connecties
| Insiders | |
|---|---|
| Dieter Weinand | 32 |
| Donald Hayden | 23 |
| Norihiro Ashida | 20 |
| Hiroshi Shirafuji | 16 |
| Robert Oliver | 14 |
| Cesare Orlandi | 11 |
| Henrietta Ukwu | 8 |
| Akihiko Otsuka | 7 |
| Yasuhisa Kurogi | 7 |
| Noriko Tojo | 7 |
| Yasuhisa Katsuta | 6 |
| Kenichiro Otake | 6 |
| Ko Sekiguchi | 6 |
| Yasuyuki Hirotomi | 5 |
| Shuichi Takagi | 5 |
- Beurs
- Insiders
- Ichiro Otsuka
- Bedrijfsconnecties
